YOLFTbeta
Little Green Pharma Ltd

Little Green Pharma Ltd

LGP · AU · Healthcare / Drug Manufacturers - Specialty & Generic

0.069AUD-0.00 (-1.43%)

Price History

Full chart

Market Stats

Previous Close0.07
Open0.07
Day Range0.069 – 0.07
52-Week Range0.06 – 0.14
Volume483.99K
Market Cap57.96M
P/E (TTM)0.00
Forward P/E12.00
EPS0.00
Dividend Yield0.00%
Beta0.32
50-Day Avg0.0708
200-Day Avg0.0927

About

Little Green Pharma Ltd produces and sells cannabis-based medicinal products across Australia and Europe. The company also provides infrastructure to support plant genetics programs and the development of its flower portfolio. It sells its products through a network of wholesalers, pharmacies, clinics, and GPs (general practitioners). The company was founded in 2016 and is based in Wembley, Australia.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Paul Frederick Long
  • Employees0
  • HeadquartersPO Box 101, Wembley, WA, Australia, 6913, Australia
  • Websitehttps://www.littlegreenpharma.com

Leadership

  • Mr. Paul Frederick LongGroup Chief Executive Officer
  • Mr. Alistair Warren B.A., L.L.B.Company Secretary & General Counsel
  • Mr. Jason RanceChief Executive Officer of Australia

Financials

Income Statement

Currency: AUD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue25854.45K248.50K2.20M7.00M14.04M19.86M25.63M36.82M42.42M
Growth (%)-+21003.49%+356.41%+786.93%+217.77%+100.47%+41.45%+29.07%+43.67%+15.21%
Cost of Revenue11.75K49.63K192.82K1.05M1.23M9.53M7.59M12.51M11.56M30.70M
Gross Profit-11.49K4.82K55.67K1.15M5.78M4.51M11.98M13.12M25.26M11.73M
Gross Margin-4453.49%8.86%22.40%52.31%82.47%32.13%60.31%51.18%68.59%27.65%
Operating Expense205.68K2.37M4.74M10.14M-18.92M32.88M26.43M25.36M29.31M13.69M
Operating Income-217.17K-2.37M-4.68M-8.99M24.70M-28.37M-14.45M-12.24M-4.05M-1.96M
Operating Margin-84174.42%-4343.73%-1884.91%-407.80%352.60%-202.07%-72.76%-47.76%-11.00%-4.62%
EBITDA-205.42K-2.32M-4.59M-8.80M25.38M-27.03M-4.64M-4.47M-684.00K1.85M
EBITDA Margin-79620.16%-4252.59%-1846.93%-399.35%362.39%-192.54%-23.38%-17.44%-1.86%4.36%
Net Income-217.15K-3.76M-5.52M-8.28M-4.36M-24.07M-9.21M-8.15M3.32M-1.41M
Net Income Margin-84168.22%-6901.78%-2220.58%-375.51%-62.20%-171.43%-46.35%-31.81%9.03%-3.32%
R&D23.80K376.36K372.79K1.01M1.78M7.22M6.59M6.32M290.00K46.00K
R&D as % of Total Revenue9223.64%691.24%150.02%45.61%25.42%51.43%33.21%24.66%0.79%0.11%
Interest Expense1531.84K4.68K400.04K91.54K724.70K928.84K602.43K384.00K553.00K
Interest Expense % of Total Revenue59.30%3.37%1.88%18.15%1.31%5.16%4.68%2.35%1.04%1.30%

Balance Sheet

Currency: AUD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets968.73K4.02M15.57M16.40M110.99M95.95M98.62M86.29M96.12M93.75M
Total Liabilities202.12K382.28K1.49M4.11M17.10M20.47M16.39M10.21M11.11M10.72M
Total Equity766.61K3.64M14.07M12.30M93.89M75.48M82.23M77.26M85.02M83.03M
Cash726.77K1.47M9.30M4.27M40.27M20.09M12.40M4.97M2.38M1.42M
Total Debt56.37K-1.33M1.69M1.42M15.87M11.87M5.14M4.67M4.69M
Net Debt-670.40K-1.47M-7.97M-2.59M-38.85M-4.21M-532.34K167.76K2.29M3.27M

Cash Flow

Currency: AUD2017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-25.24K-1.57M-3.32M-6.05M-5.15M-17.17M-6.94M67.00K-917.00K39.00K
Investing Cash Flow-43.94K-415.32K1.03M-7.08M-12.73M-7.66M-14.03M-2.80M-1.14M-948.00K
Financing Cash Flow795.95K2.73M1.32M16.93M53.87M4.73M13.03M-4.72M-530.00K25.00K
Capital Expenditure89.61K298.95K473.87K6.81M1.06M7.66M4.93M716.00K237.00K829.00K
Free Cash Flow-114.86K-1.87M-3.80M-12.86M-6.21M-24.83M-11.87M-649.00K-1.15M-790.00K
Dividends Paid---8.48M1.02M-5.81M2.55M3.90M-
FCF to OCF455.04%119.03%114.27%212.60%120.61%144.62%171.02%-968.66%125.85%-2025.69%
Dividend Paid to FCF----65.91%-16.36%--48.97%-392.36%-338.02%-

Earnings

Report DateFeb 19, 2020Aug 31, 2020Feb 23, 2021Sep 28, 2021Oct 26, 2021Feb 27, 2022May 30, 2022Sep 29, 2022Nov 30, 2022Mar 1, 2023May 31, 2023Aug 30, 2023Nov 30, 2023Feb 21, 2024May 30, 2024Aug 28, 2024Nov 26, 2024Feb 10, 2025May 29, 2025Sep 3, 2025Nov 19, 2025Jan 29, 2026
EPS Estimate0.000.000.000.000.00-0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual-0.01-0.030.000.140.00-0.04-0.080.00-0.030.000.000.000.000.000.000.00-0.01-0.010.020.000.000.00
Surprise----------------------
Timing-----After-hours-After-hoursPre-market-Pre-market-Pre-marketAfter-hours--------

Key Statistics & Ratios

Market Cap57.96M
Enterprise Value62.89M
Trailing P/E0.00
Forward P/E12.00
Price / Sales0.77
Price / Book0.72
EPS0.00
Book Value0.189
Revenue (TTM)75.50M
Gross Profit (TTM)39.91M
EBITDA9.06M
Profit Margin4.23%
Operating Margin11.00%
Return on Equity14.01%
Return on Assets8.32%
Shares Outstanding827.98M
Shares Float195.10M
Beta0.32
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%